| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $301.1M | +2.4% | +9.1% |
| Cost of Revenue | $61.6M | +0.1% | +10.8% |
| Gross Profit | $239.5M | +3.0% | +8.7% |
| R&D Expense | $73.9M | +3.1% | +9.0% |
| SG&A Expense | $37.5M | -1.4% | +11.2% |
| Operating Income | $25.1M | +21.8% | +7.1% |
| Interest Expense | $2.7M | +0.1% | +66.6% |
| Pre-tax Income | $27.4M | +15.4% | +58.5% |
| Income Tax | $15.3M | +49.0% | +248.7% |
| Net Income | $12.1M | -10.3% | -6.4% |
| EPS (Basic) | $0.05 | -16.7% | +0.0% |
| EPS (Diluted) | $0.05 | +0.0% | +0.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $633.2M | -3.7% | +4.0% |
| Short-term Investments | $96.5M | -3.5% | +8.2% |
| Accounts Receivable | $204.9M | +8.1% | +8.7% |
| Current Assets | $1.02B | -1.8% | +6.4% |
| Total Assets | $1.61B | -0.9% | +18.8% |
| Current Liabilities | $853.0M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $246.1M | — | — |
| Capital Expenditures | $4.2M | — | — |
| Investing Cash Flow | -$26.2M | — | — |
| Financing Cash Flow | -$216.9M | — | — |
| Free Cash Flow | $241.9M | — | — |
| +45.3% |
| Long-term Debt | $450.4M | +0.1% | -30.9% |
| Total Liabilities | $1.40B | +0.1% | +4.4% |
| Stockholders' Equity | -$286.6M | -6.4% | +40.3% |